Pirbright has been awarded £100,000 to support innovative research and promote knowledge exchange.
This funding was given by UK Research and Innovation (UKRI) in its Impact Acceleration Account (IAA) which aims to support early-stage translation of UK research to have real-life impact.
Following an internal call for proposals that could be supported by this funding, there was a selection process which was undertaken by Pirbright’s Science Committee resulting in a total of seven new projects being funded:
| Claire Cayol | New methods for in-depth exploration of skin-specific volatile compounds and the influence of skin microbiota on the skin volatilome in bluetongue infected ruminants |
| Claire Colenutt | Determining particulate matter emission profiles on farms in the study of airborne transmission of foot-and-mouth disease virus |
| Georgina Limon-Vega | Validation of mobile app to estimate impact of small ruminants’ diseases in real time in Nigeria. |
| Helena Maier | Characterising the mechanism of 2-DG inhibition of coronavirus RNA synthesis |
| Jane Edwards | Evaluation of RNA-vectored delivery of Porcine reproductive and respiratory syndrome virus glycoproteins as a novel vaccine platform to combat emergent strains |
| Priscilla Tng | Luciferase Immunoprecipitation Assay screening of antibodies targeting African swine fever |
| Sarah Keep | A methodology to universally attenuate infectious bronchitis virus strains |
We’d like to thank everyone for their applications and congratulate those who were successful.
Lizelle Gouverneur, Head of Business Development, said: “We are proud of the high quality of research that we conduct at Pirbright and are delighted to have received this IAA funding which can support even more innovative ways to tackle diseases that impact the health of people and our livestock. We very much look forward to following and sharing the progress of these newly funded projects.”
Image: Copyright Mark Bourdillon